Registration Dossier

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Type of genotoxicity: chromosome aberration
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Study period:
1999-09-21 to 1999-11-12
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: GLP-Guideline study. According to the ECHA guidance document "Practical guide 6: How to report read-across and categories (March 2010)", the reliability was changed from RL1 to RL2.

Data source

Reference Type:
study report
Report Date:

Materials and methods

Test guideline
according to
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
GLP compliance:
Type of assay:
micronucleus assay

Test material

Details on test material:
- Name of test material (as cited in study report): Zeostop X (silver alumino-silikate)
- Chemical name: Zeolite, cuboidal, crystalline, synthetic, non-fibrous
- Framework: cuboidal
- Related CAS number: 1318-02-1
- Analytical purity: approx. 100%
- Lot/batch No.: MR 453 136
- Physical state: white powder
- Composition of test material, percentage of components (surface modified with Ag): Si/Al molarity 1.24
Al2O3: 25.6%
CaO 0.08%
Fe2O3 0.00%
K2O 00.08%
MgO 00.00%
Na2O 11.71%
SiO2 37.33%
Ag2O 02.80%
loss resulting from combustion (900°C)
- Expiry date: May 2000
- Storage: in dark and at room temperature

Test animals

Details on test animals and environmental conditions:
Swiss Ico: OF1 (IOPS Caw) mice

Administration / exposure

Route of administration:
oral: gavage
0.5% aqueous methylcellulose
Details on exposure:
In the main study, three groups of five male and five female Swiss Ico: OF1 (IOPS Caw) mice received four oral treatments of ZEOSTOP X at dose-levels of 1250, 2500 and 5000 mg/kg/day, at a 24-hour interval. Due the low number of available animals in the female vehicle control group, the experiment was repeated for females only, at the same dose-levels.
One group of five males and five females received the vehicle (0.5% aqueous methylcellulose) under the same experimental conditions, and acted as control group.
One group of five males and five females received the positive control test substance (cyclophosphamide) once by oral route at the dose-level of 50 mg/kg.
Duration of treatment / exposure:
four treatments separated by 24 hours (volume: 10 mL/kg)
Frequency of treatment:
four treatments separated by 24 hours
Post exposure period:
24 h
Doses / concentrations
Doses / Concentrations:
0 (vehicle), 1250, 2500 and 5000 mg/kg/day
nominal conc.
No. of animals per sex per dose:
Control animals:
yes, concurrent vehicle
Positive control(s):
cyclophosphamide, 50 mg/kg


Tissues and cell types examined:
bone marrow, micronucleated polychromatic erythrocytes (MPE), polychromatic (PE) and normochromatic erythrocyte (NE) ratio
Details of tissue and slide preparation:
The animals of the treated and vehicle control groups were killed 24 hours after the last treatment and the animals of the positive control group were killed 24 hours after the single treatment. Bone marrow smears were then prepared.
Evaluation criteria:
For each animal, the number of the micronucleated polychromatic erythrocytes (MPE) was counted in 2000 polychromatic erythrocytes. The polychromatic (PE) and normochromatic erythrocyte (NE) ratio was established by scoring a total of 1000 erythrocytes (PE + NE).

Results and discussion

Test results
no effects
Vehicle controls validity:
Negative controls validity:
not examined
Positive controls validity:
Additional information on results:
The test substance was non-toxic in the preliminary test at 5000 mg/kg/day, this dose-level was selected as the highest one for treatment in the main test.
In the main test, for males the mean values of MPE in the groups treated with the test substance, were equivalent to those of the vehicle control group. The PE/NE ratio was significantly lower (p < 0.05) when compared to that of the vehicle group, in the group given 5000 mg/kg/day,
showing that the bone marrow cells were effectively exposed to the test substance.
For females the mean values of MPE as well as the PE/NE ratio in the groups treated with the test substance, were equivalent to those of the vehicle control group and no significant difference was noted.

The mean values of MPE as well as the PE/NE ratio for the vehicle and positive controls were consistent with historical data of the laboratory. Cyclophosphamide induced a highly significant increase (p < 0.001) in the frequency of MPE, indicating the sensitivity of the test system under the experimental conditions.

Group MPE/1000PE PE/NE ratio
[mg/kg/d] mean mean
Vehic. 1.1 0.8
1250 0.7 0.7
2500 1.3 0.7
5000 1.0 0.6*
Cyclo. 20.8*** 0.9

Group MPE/1000PE PE/NE ratio
[mg/kg/d] mean mean
Vehic. 0.4 0.7
1250 0.8 0.9
2500 0.7 0.8
5000 1.1 0.7
Cyclo. 38.9*** 0.7


Applicant's summary and conclusion

Interpretation of results (migrated information): negative